Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
1.4%
1w
9.6%
1m
9.4%
3m
1.8%
6m
26.9%
1y
45.8%
5y
37.8%
all
29.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 7.16 1.4%
5.65
8.99
Company Overview

Sales
25.3 Cr
Growth: -25.7%
Profit after Tax
-34.1 Cr
Growth: -22.9%
Micro Cap
35.9 Cr
P/S: 1.4x
Industry P/S: 2.6x
Fundamentals

Sales (Cr) ₹ 25.3
Growth -25.7%
EBITDA N/A
P/S 1.4x
Dividend 0.0%
P/E -1.1x
Book Value ₹ 8.11
PEG Ratio 0.0x
ROE -73.2%
P/B 0.9x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)